Himanshu Rawal MD

962 posts

Himanshu Rawal MD banner
Himanshu Rawal MD

Himanshu Rawal MD

@rawalmd

PCCSM physician |MAMC alum l tweets my own 🇮🇳🇺🇸

Katılım Eylül 2017
366 Takip Edilen434 Takipçiler
Himanshu Rawal MD retweetledi
𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊
Great schema! But beware that *any* time you see a diagram like this, it assumes the patient has one disease process. Our patients are increasingly multimorbid so: ⚠️May have >1 cause of hypoNa ⚠️Fixing one cause may cause dominant physiology to shift (playing wack-a-mol)
Shreshta Tripathi@ShreshtaT

🔥Hyponatremia made simple Dr Ajay Kher: 1️⃣ Serum Osm → hypo vs pseudo 2️⃣ Urine Osm → <100 = polydipsia, >100 = ADH present 3️⃣ Urine Na → <20 = volume depletion, >40 = SIADH 🙇‍♀️Structured thinking = faster diagnosis. #CNSICON2026 @CNSI2026 @VinBhargava @rajdebsaha @drvt87

English
4
16
129
14K
Himanshu Rawal MD retweetledi
Paul Wischmeyer MD
Paul Wischmeyer MD@Paul_Wischmeyer·
Peripheral vasopressor administration in critically ill adults was associated with a low incidence of adverse events—major events were rare using short peripheral intravenous catheters, and use avoided central venous catheter placement in 60% of cases. ja.ma/4btNGSr
Paul Wischmeyer MD tweet media
English
0
12
30
3.7K
Himanshu Rawal MD retweetledi
Gurleen Kaur, MD
Gurleen Kaur, MD@Gurleen_Kaur96·
Defibrillation 2.0 by Dr. Corcoran #REVIVE2026 AP pad placement allows 🔺Better vector 🔺 Less impedence Dual sequential external defibrillation (DSED) AHA guidelines: Class 2b recom ILCOR: DSED suggested strategy for VF refractory to shocks @CardioNerds @OscarJMitchell
Gurleen Kaur, MD tweet mediaGurleen Kaur, MD tweet media
English
1
29
90
9.9K
Himanshu Rawal MD retweetledi
NEJM
NEJM@NEJM·
In the phase 3 TETON-2 trial involving patients with idiopathic pulmonary fibrosis, inhaled treprostinil was associated with a smaller decline in forced vital capacity and a lower risk of clinical worsening than placebo over 52 weeks. Full trial results: nejm.org/doi/full/10.10…
NEJM tweet media
English
3
38
98
18.7K
Himanshu Rawal MD retweetledi
Hayley Gershengorn
Hayley Gershengorn@HBGMD·
😵‍💫 Are you confused by Bayesian methods? Do you worry you’re alone? 🫢 Just in #journal_CHESTCritCare, B Malley et al eval how intensivists differently interpret results from Bayesian and frequentist trials… chestcc.org/article/S2949-… …I’m a bit unsettled by their findings 😉
Hayley Gershengorn tweet media
English
0
3
9
639
Himanshu Rawal MD retweetledi
Manik Aggarwal
Manik Aggarwal@ManikGIMD·
Great to see this study in press where we show the utility of a sleep positioning device in managing GERD after lung transplant. Novel, safe and cost effective solution to a major problem in this population. Thankful to ACG for the research award! @ScottGabbardMD
Manik Aggarwal tweet mediaManik Aggarwal tweet media
English
1
4
11
2.4K
Himanshu Rawal MD retweetledi
M Velia Antonini
M Velia Antonini@FOAMecmo·
Understanding lung physiology through ventilator screen 🫁 airway pressure waveform at a glance: respiratory system equation of motion, conductive pressure, stress index, driving pressure 🌊 flow waveform during pressure-controlled ventilation 💨 expiratory flow and the time constant of the respiratory system 🛌 dynamic bedside maneuvers: airway opening pressure, recruitability & recruitment-to-inflation ratio 🚧 the way forward #FOAMcc 🔓 rdcu.be/e6iG6
M Velia Antonini tweet media
English
1
66
213
8.8K
Himanshu Rawal MD retweetledi
ATS Blue Journal
ATS Blue Journal@ATSBlueEditor·
Right Ventricular Hemodynamics in Acute Respiratory Distress Syndrome: Monitoring and Implications for Clinical Management @atscommunity 🔗 tinyurl.com/4ea9hua2
ATS Blue Journal tweet media
English
0
37
112
7.1K
Himanshu Rawal MD retweetledi
Eric Topol
Eric Topol@EricTopol·
The time of day for cancer immunotherapy is associated with major outcomes. Early is better. Results from a randomized trial of lung cancer, backs up the importance of our circadian rhythm and immune system nature.com/articles/s4159…
Eric Topol tweet media
English
49
336
1.4K
541.4K
Himanshu Rawal MD retweetledi
IMCrit
IMCrit@IM_Crit_·
*Pulmonary embolism* versus *Acute myocardial infarction*: Above and below the pen: the size of the clots in each scenario I was looking for a picture like this and found it in a lecture by Dr Sripal Bangalore #foamed #foamcc #meded #MedTwitter
IMCrit tweet media
English
6
57
270
24.7K
Himanshu Rawal MD retweetledi
M Velia Antonini
M Velia Antonini@FOAMecmo·
Alveolar gas equation and its clinical implications 🧮 derivation & application of AGE 💨 fraction of inspired O2 💨 atmospheric pressure 🩸PaCO2 & respiratory exchange ratio 🫁 PAO2 & A–a gradient in the approach of hypoxemia & pulmonary shunt #FOAMcc 🔓 rdcu.be/eZtD8
M Velia Antonini tweet media
English
2
87
292
27K
Himanshu Rawal MD retweetledi
JAMA
JAMA@JAMA_current·
Post–intensive care syndrome (PICS) is a cluster of physical, cognitive, and psychological impairments that affect more than half of ICU survivors. 💡 Learn more about the diagnosis, treatment, and prevention of PICS in this JAMA Insights. ja.ma/4sy0ij4
JAMA tweet media
English
2
62
197
15.8K
Himanshu Rawal MD retweetledi
Kiran Rikhraj
Kiran Rikhraj@KiranRikhraj·
1/ #POCUS pop quiz Elderly female with no PMHx presented with confusion, hypoxemia, rapid Afib and hypotension. Receives 3L of IVF and started on NE at 0.5ug/kg/min. This is her CXR:
Kiran Rikhraj tweet media
English
3
28
61
20K
Himanshu Rawal MD retweetledi
Nick Mark MD
Nick Mark MD@nickmmark·
Big news: Results of the HIGHLY anticipated RSI trial: Ketamine vs Etomidate 🥁 Drumroll... n=2,365 pts 1° No difference in mortality (28.1 vs 29.1%) 2° Ketamine associated with WORSE hemodynamic outcomes (SBP <65, new/increased vasopressor requirement, or cardiac arrest): 17 vs 22% #CCRDownUnder
Nick Mark MD tweet mediaNick Mark MD tweet media
English
9
43
215
40.2K
Himanshu Rawal MD retweetledi
𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊
It's honestly hard to know how to interpret this data due to statistical power limitations. This is an important trial that should change practice. But I don't think we should all jump on the bandwagon that ketamine is a bad RSI drug. fresh blog: emcrit.org/pulmcrit/rsitr…
GIF
English
2
6
32
25.4K
Himanshu Rawal MD retweetledi
M Velia Antonini
M Velia Antonini@FOAMecmo·
Mastering vasopressin in septic shock, pragmatic bedside guidance on its optimal use, emphasizing real-world constraints & evidence gaps: 💉 clinical pharmacology ⚖️ dosing ⏱️ timing 🩺 practical considerations #FOAMcc 🔓 rdcu.be/ePAno
M Velia Antonini tweet media
English
2
108
279
13.9K
Himanshu Rawal MD retweetledi
Ross Prager
Ross Prager@ross_prager·
(1/x) Andromeda-Shock 2 was just published in JAMA and is the most important septic shock trial in the past DECADE. They found that phenotyped resuscitation improves the composite outcome of mortality, vital support, and hospital LOS. Here's how you can apply this protocol to your practice 👇
Ross Prager tweet media
English
18
277
674
167.6K
Himanshu Rawal MD retweetledi
ANDROMEDA-SHOCK
ANDROMEDA-SHOCK@AndromedaShock·
A simplified ANDROMEDA- SHOCK-2 algorithm display by Jesus Nieves from Spain! As he said complex at first glance but quite easy when practicing!! Thanks Jesus😍😍
ANDROMEDA-SHOCK tweet media
English
3
141
532
29.1K
Himanshu Rawal MD retweetledi
ANDROMEDA-SHOCK
ANDROMEDA-SHOCK@AndromedaShock·
Dear all, unless you are already involved or practice or love the concept of physiology-oriented personalized resuscitation, I humbly but strongly 😍recommend reading before entering A2, several background articles to facilitate the flow: PMIDs 40999130, 40537864, 40163133,
English
1
44
167
10.3K